In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
All content for RheumMadness Rheumatology Podcast is the property of RheumMadness and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship ProgramCD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship ProgramSTRAP trial, by the Emerging EULAR Network (EMEUNET) Links to theMednet.org Q&As about this region: In the trea...
RheumMadness Rheumatology Podcast
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
